title: Progress in PARP inhibitors beyond BRCA mutant recurrent ovarian cancer?
authors.affiliation: MD Anderson Cancer Center Madrid, Madrid 28033, Spain. Electronic address: agonzalezm@seom.org.
authors.forename: Antonio
authors.initials: A
authors.lastname: González Martín
mesh_terms: D005260:Female; D006801:Humans; D009375:Neoplasms, Glandular and Epithelial; D010051:Ovarian Neoplasms; D000067856:Poly(ADP-ribose) Polymerase Inhibitors
chemical_list: D000067856:Poly(ADP-ribose) Polymerase Inhibitors